Technopath Clinical Diagnostics, which offers quality controls and software for clinical laboratories, has announced a significant expansion in manufacturing capacity to support the rapid growth of its Multichem and IAMQC product range.
The company is investing €5m to more than triple its manufacturing capacity in Ballina, Co. Tipperary to meet growing international demand for its range of quality controls and software for hospital and clinical laboratories.
The products are used in over 5,000 laboratories in 110 countries globally and achieved Chinese regulatory approval during 2015.
The investment will result in the creation of 60 new jobs over the next two years, bringing the total employment numbers on site to 180.
Malcolm Bell, co-founder and CEO, said: “This further investment will solidify the company’s position as a significant employer in Tipperary, strongly supporting the local economy. It demonstrates that, thanks to the business-friendly environment created by Government, world-class companies can emerge from relatively small towns like Ballina and create large scale high-value employment in manufacturing and R&D.”
Bell continued: “I am very proud to say that this significant expansion is the result of a combined effort by our team over the last 10 years to create a world-class range of third-party quality control products for the global healthcare market. Our range is best-in-class on a global scale and, having already experienced rapid growth over the past 18 months, we are now very confident about the future for our business.”